Literature DB >> 11439091

Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction.

S Tamura1, N Matsumoto, A Imamura, N Shimozawa, Y Suzuki, N Kondo, Y Fujiki.   

Abstract

The peroxisome biogenesis disorders (PBDs), including Zellweger syndrome (ZS), neonatal adrenoleucodystrophy (NALD) and infantile Refsum disease (IRD), are fatal autosomal recessive diseases caused by impaired peroxisome biogenesis, of which 12 genotypes have been reported. ZS patients manifest the severest clinical and biochemical abnormalities, whereas those with NALD and IRD show less severity and the mildest features respectively. We have reported previously that temperature-sensitive peroxisome assembly is responsible for the mildness of the clinical features of IRD. PEX1 is the causative gene for PBDs of complementation group E (CG-E, CG1 in the U.S.A. and Europe), the PBDs of highest incidence, encoding the peroxin Pex1p of the AAA ATPase family. It has been also reported that Pex1p and Pex6p interact with each other. In the present study we investigated phenotype-genotype relationships of CG1 PBDs. Pex1p from IRD such as Pex1p with the most frequently identified mutation at G843D was largely degraded in vivo at 37 degrees C, whereas a normal level of Pex1p was detectable at the permissive temperature. In contrast, PEX1 proteins derived from ZS patients, including proteins with a mutation at L664P or the deletion of residues 634-690, were stably present at both temperatures. Pex1p-G843D interacted with Pex6p at approx. 50% of the level of normal Pex1p, whereas Pex1p from ZS patients mostly showing non-temperature-sensitive peroxisome biogenesis hardly bound to Pex6p. Taking these results together, we consider it most likely that the stability of Pex1p reflects temperature-sensitive peroxisome assembly in IRD fibroblasts. Failure in Pex1p-Pex6p interaction gives rise to more severe abnormalities, such as those manifested by patients with ZS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439091      PMCID: PMC1221968          DOI: 10.1042/0264-6021:3570417

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Isolation and characterization of novel peroxisome biogenesis-defective Chinese hamster ovary cell mutants using green fluorescent protein.

Authors:  K Ghaedi; A Kawai; K Okumoto; S Tamura; N Shimozawa; Y Suzuki; N Kondo; Y Fujiki
Journal:  Exp Cell Res       Date:  1999-05-01       Impact factor: 3.905

2.  Genetic basis of peroxisome-assembly mutants of humans, Chinese hamster ovary cells, and yeast: identification of a new complementation group of peroxisome-biogenesis disorders apparently lacking peroxisomal-membrane ghosts.

Authors:  N Shimozawa; Y Suzuki; Z Zhang; A Imamura; N Kondo; N Kinoshita; Y Fujiki; T Tsukamoto; T Osumi; T Imanaka; T Orii; F Beemer; P Mooijer; C Dekker; R J Wanders
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

3.  Temperature-sensitive phenotypes of peroxisome-assembly processes represent the milder forms of human peroxisome-biogenesis disorders.

Authors:  A Imamura; T Tsukamoto; N Shimozawa; Y Suzuki; Z Zhang; T Imanaka; Y Fujiki; T Orii; N Kondo; T Osumi
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 4.  Peroxisome biogenesis and peroxisome biogenesis disorders.

Authors:  Y Fujiki
Journal:  FEBS Lett       Date:  2000-06-30       Impact factor: 4.124

Review 5.  Peroxisome biogenesis disorders: genetics and cell biology.

Authors:  S J Gould; D Valle
Journal:  Trends Genet       Date:  2000-08       Impact factor: 11.639

6.  The peroxin pex3p initiates membrane assembly in peroxisome biogenesis.

Authors:  K Ghaedi; S Tamura; K Okumoto; Y Matsuzono; Y Fujiki
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

7.  Newly identified Chinese hamster ovary cell mutants are defective in biogenesis of peroxisomal membrane vesicles (Peroxisomal ghosts), representing a novel complementation group in mammals.

Authors:  N Kinoshita; K Ghaedi; N Shimozawa; R J Wanders; Y Matsuzono; T Imanaka; K Okumoto; Y Suzuki; N Kondo; Y Fujiki
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

8.  Temperature-sensitive mutation in PEX1 moderates the phenotypes of peroxisome deficiency disorders.

Authors:  A Imamura; S Tamura; N Shimozawa; Y Suzuki; Z Zhang; T Tsukamoto; T Orii; N Kondo; T Osumi; Y Fujiki
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

9.  Fusion of small peroxisomal vesicles in vitro reconstructs an early step in the in vivo multistep peroxisome assembly pathway of Yarrowia lipolytica.

Authors:  V I Titorenko; H Chan; R A Rachubinski
Journal:  J Cell Biol       Date:  2000-01-10       Impact factor: 10.539

10.  Inhibitors of COPI and COPII do not block PEX3-mediated peroxisome synthesis.

Authors:  S T South; K A Sacksteder; X Li; Y Liu; S J Gould
Journal:  J Cell Biol       Date:  2000-06-26       Impact factor: 10.539

View more
  11 in total

1.  A peroxisome deficiency-induced reductive cytosol state up-regulates the brain-derived neurotrophic factor pathway.

Authors:  Yuichi Abe; Masanori Honsho; Ryoko Kawaguchi; Takashi Matsuzaki; Yayoi Ichiki; Masashi Fujitani; Kazushirou Fujiwara; Masaaki Hirokane; Masahide Oku; Yasuyoshi Sakai; Toshihide Yamashita; Yukio Fujiki
Journal:  J Biol Chem       Date:  2020-03-12       Impact factor: 5.157

2.  The PEX1 ATPase Stabilizes PEX6 and Plays Essential Roles in Peroxisome Biology.

Authors:  Mauro A Rinaldi; Wendell A Fleming; Kim L Gonzalez; Jaeseok Park; Meredith J Ventura; Ashish B Patel; Bonnie Bartel
Journal:  Plant Physiol       Date:  2017-06-09       Impact factor: 8.340

3.  Shuttling mechanism of peroxisome targeting signal type 1 receptor Pex5: ATP-independent import and ATP-dependent export.

Authors:  Non Miyata; Yukio Fujiki
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

4.  Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation.

Authors:  Naomi Matsumoto; Shigehiko Tamura; Satomi Furuki; Non Miyata; Ann Moser; Nobuyuki Shimozawa; Hugo W Moser; Yasuyuki Suzuki; Naomi Kondo; Yukio Fujiki
Journal:  Am J Hum Genet       Date:  2003-07-08       Impact factor: 11.025

5.  Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels.

Authors:  Maria João Nabais Sá; Júlio C Rocha; Manuela F Almeida; Carla Carmona; Esmeralda Martins; Vasco Miranda; Miguel Coutinho; Rita Ferreira; Sara Pacheco; Francisco Laranjeira; Isaura Ribeiro; Ana Maria Fortuna; Lúcia Lacerda
Journal:  JIMD Rep       Date:  2015-08-25

6.  AAA peroxins and their recruiter Pex26p modulate the interactions of peroxins involved in peroxisomal protein import.

Authors:  Shigehiko Tamura; Naomi Matsumoto; Ryota Takeba; Yukio Fujiki
Journal:  J Biol Chem       Date:  2014-07-11       Impact factor: 5.157

7.  Characterization of two common 5' polymorphisms in PEX1 and correlation to survival in PEX1 peroxisome biogenesis disorder patients.

Authors:  Sven Thoms; Sabine Grønborg; Jana Rabenau; Andreas Ohlenbusch; Hendrik Rosewich; Jutta Gärtner
Journal:  BMC Med Genet       Date:  2011-08-16       Impact factor: 2.103

8.  Deletion of a single allele of the Pex11β gene is sufficient to cause oxidative stress, delayed differentiation and neuronal death in mouse brain.

Authors:  Barbara Ahlemeyer; Magdalena Gottwald; Eveline Baumgart-Vogt
Journal:  Dis Model Mech       Date:  2011-10-04       Impact factor: 5.758

9.  Protein-protein interactions more conserved within species than across species.

Authors:  Sven Mika; Burkhard Rost
Journal:  PLoS Comput Biol       Date:  2006-05-18       Impact factor: 4.475

Review 10.  Pexophagy: Molecular Mechanisms and Implications for Health and Diseases.

Authors:  Dong-Hyung Cho; Yi Sak Kim; Doo Sin Jo; Seong-Kyu Choe; Eun-Kyeong Jo
Journal:  Mol Cells       Date:  2018-01-23       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.